India  
NewsR.in
> >

Kentucky accuses Endo of contributing to opioid epidemic

Reuters India Monday, 6 November 2017
(Reuters) - Kentucky accused units of Endo International Plc on Monday of contributing to drug overdoses by deceptively marketing its painkiller Opana ER, in the latest lawsuit by state or local governments against the drugmaker amid an opioid epidemic.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Tweets about this


Other recent news in Health

AP Explains: What to look for in Irish abortion REFERENDUMAsteroid Impact That Wiped Out The Dinosaurs Also Caused Abrupt GLOBAL WARMING
NOAA Expects HURRICANE SEASON For 2018 To Be Near Or Above Normal

Recent related videos

News video: Covington filing suit against opioid companies

▶ Covington filing suit against opioid companies 01:39

The city is fighting risings costs of the heroin epidemic.
Source: WCPO Cincinnati -

News video: For U.S. surgeon general, addiction treatment is deeply personal

▶ For U.S. surgeon general, addiction treatment is deeply personal 02:32

For U.S. Surgeon General Dr. Jerome Adams, addiction treatment is deeply personal. As he promoted the use of naloxone in Northern Kentucky, he talked about how his brother is in prison for theft to pay..
Source: WCPO Cincinnati -

News video: In Northern Kentucky, Surgeon General emphasizes importance of naloxone

▶ In Northern Kentucky, Surgeon General emphasizes importance of naloxone 01:16

During a visit to Northern Kentucky, U.S. Surgeon General Jerome M. Adams emphasized the importance of naloxone in combatting the opioid epidemic.
Source: Rumble -

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2018 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter